Clinical Trial Update: Maintenance Treatment of Iron Deficiency in IBD Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing maintenance iron therapy for iron deficiency in patients with inflammatory bowel disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Vifor Pharma | Conditions: Iron Deficiency, Inflammatory Bowel Disease | Phase 3 | Status: COMPLETED